Pursuant to Second proviso to Regulation 30(6) and Regulation 33 of the SEBI (Listing Obligations an Disclosure Requirements) Regulations, 2015 we hereby inform you that the Board of Directors of the Company, in their meeting held on today i.e. Tuesday 4th February 2025 at the Registered Office of th Company and transacted the following major businesses: 1.) Considered and approved Un-audited financial results for the quarter and nine months ended on 31 sit December 2024. The board meeting commented at 03:30 PM and concluded at 04:00 PM Thanking You.

pdf

Shree Ganesh Bio-Tech (India) Ltd.

20 Jan 2025

0.93

-2.11%

Board Meeting

Shree Ganesh Biotech (India) Ltd - 539470 - Board Meeting Intimation for Compliance Of Regulation 29 …

BSE India

Shree Ganesh Biotech (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/02/2025 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that a meeting of the Board of Directors of the Company will be held on Tuesday 4th February 2025 inter alia, to consider following business. - 1.) To approve and take on record the Un-Audited Financial Results of the Company for the quarter ended on 31st December 2024. 2.) Any other matter with the permission of the board which the Board may think fit. Please take the above intimation in your records. Thanking You. Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that a meeting of the Board of Directors of the Company will be held on Tuesday 4th February 2025 inter alia, to consider following business. - 1.) To approve and take on record the Un-Audited Financial Results of the Company for the quarter ended on 31st December 2024. 2.) Any other matter with the permission of the board which the Board may think fit. Please take the above intimation in your records. Thanking You.

pdf